SBT115301 + Placebo

Phase 1Completed
0 watching 0 views this week๐Ÿ’ค Quiet
25
Hype Score

Development Stage

โœ“
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Safety

Conditions

Safety

Trial Timeline

Jul 25, 2022 โ†’ Jan 3, 2024

About SBT115301 + Placebo

SBT115301 + Placebo is a phase 1 stage product being developed by Sonoma Pharmaceuticals for Safety. The current trial status is completed. This product is registered under clinical trial identifier NCT05388981. Target conditions include Safety.

Hype Score Breakdown

Clinical
10
Activity
5
Company
2
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT05388981Phase 1Completed

Other Products from Sonoma Pharmaceuticals